CVE-2026-62187OpenClaw < 2026.6.9 Feishu tools Authorization Bypass
Updated under an hour ago ()
Does this affect you?
It affects openclaw feishu and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw Feishu tools (npm package @openclaw/feishu) in versions <= 2026.6.6 could ignore per-account disablement. A lower-trust caller or a configured input path could perform actions that should have required a stronger authorization or policy check, resulting in unauthorized operations. The issue is fixed in version 2026.6.9. Impact depends on the operator's configuration and whether lower-trust input can reach the affected feature.
- CVSS
- 8.1 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-863
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Analyzed
- Record last updated
- Oct 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw feishu openclaw:feishu (from the name) | before 2026.6.9; 2026.6.9 not affected | CNA record |
openclaw openclaw/feishu openclaw:openclaw/feishu | before 2026.6.9 | NVD |
References
- https://github.com/openclaw/openclaw/security/advisories/GHSA-2q7j-2vhx-56g8vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-feishu-tools-authorization-bypassthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.